Cargando…
Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182631/ https://www.ncbi.nlm.nih.gov/pubmed/25268802 http://dx.doi.org/10.1371/journal.pone.0110069 |
| _version_ | 1782337571938893824 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4182631 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41826312014-10-07 Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes PLoS One Correction Public Library of Science 2014-09-30 /pmc/articles/PMC4182631/ /pubmed/25268802 http://dx.doi.org/10.1371/journal.pone.0110069 Text en © 2014 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Correction Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes |
| title | Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes |
| title_full | Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes |
| title_fullStr | Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes |
| title_full_unstemmed | Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes |
| title_short | Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes |
| title_sort | correction: pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182631/ https://www.ncbi.nlm.nih.gov/pubmed/25268802 http://dx.doi.org/10.1371/journal.pone.0110069 |
| work_keys_str_mv | AT correctionpharmacodynamiceffectsofcanagliflozinasodiumglucosecotransporter2inhibitorfromarandomizedstudyinpatientswithtype2diabetes |